Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Five Prime partners again with Glaxo, this time in respiratory diseases

Executive Summary

Five Prime Therapeutics Inc. (large-molecule candidates for cancer, respiratory, and autoimmune disorders) has granted GlaxoSmithKline PLC exclusive rights to its drug discovery tools--including the biotech’s library of functional human secreted proteins and transmembrane receptor proteins--to generate up to six respiratory disease programs.

Deal Industry
  • Pharmaceuticals
  • Biotechnology
    • Large Molecule
    • Drug Discovery Tools
      • Genomics-Proteomics
Deal Status
  • Final
Deal Type
  • Alliance
    • Includes Equity
    • Includes Royalty or Profit Split Information
    • R&D and Marketing (Licensing)

Related Companies

UsernamePublicRestriction

Register